Anabolic-Androgenic Steroid Use in the Eastern Mediterranean Region: a Scoping Review of Extant Empirical Literature

ACMD. (2010). Consideration of the Anabolic Steroids. Retrieved from London (UK)

Al-Falasi, O., Al-Dahmani, K., Al-Eisaei, K., Al-Ameri, S., Al-Maskari, F., Nagelkerke, N., & Schneider, J. (2008). Knowledge, attitude and practice of anabolic steroids use among gym users in Al-Ain district, United Arab Emirates. The Open Sports Medicine Journal, 2, 75–81.CrossRef

Al Bishi, K. A., & Afify, A. (2017). Prevalence and awareness of anabolic androgenic steroids (AAS) among gymnasts in the western province of Riyadh, Saudi Arabia. Electronic Physician, 9(12), 6050–6057. https://doi.org/10.19082/6050 Retrieved from http://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=29560159&site=ehost-live.CrossRefPubMedPubMedCentral

Al Ghobain, M., Konbaz, M. S., Almassad, A., Alsultan, A., Al Shubaili, M., & AlShabanh, O. (2016). Prevalence, knowledge and attitude of prohibited substances use (doping) among Saudi sport players. Substance Abuse Treatment Prevention and Policy, 11. https://doi.org/10.1186/s13011-016-0058-1 Retrieved from <Go to ISI>://WOS:000374532400001..

Al Nozha, O. M., & Elshatarat, R. A. (2017). Influence of knowledge and beliefs on consumption of performance enhancing agents in north-western Saudi Arabia. Annals of Saudi Medicine, 37(4), 317–325. https://doi.org/10.5144/0256-4947.2017.317 Retrieved from <Go to ISI>://WOS:000407680900009.CrossRefPubMedCentral

Alharbi, F. F., Gamaleddin, I., Alharbi, S. F., Almodayfer, O., Allohidan, F., Alghobain, M., et al. (2019). Knowledge, attitudes and use of anabolic-androgenic steroids among male gym users: a community based survey in Riyadh, Saudi Arabia. Saudi Pharmaceutical Journal, 27(2), 254–263. https://doi.org/10.1016/j.jsps.2018.11.007 Retrieved from <Go to ISI>://WOS:000457101600015 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362160/pdf/main.pdf.CrossRefPubMed

Allafi, A., Almansour, F., & Alreshoud, A. (2019). The use of anabolic hormones by Kuwaiti males. Science & Sports, 34(1), 40–44. https://doi.org/10.1016/j.scispo.2018.08.003 Retrieved from https://ac.els-cdn.com/S0765159718302855/1-s2.0-S0765159718302855-main.pdf?_tid=d618bbde-5500-43af-a45b-101596d0fde3&acdnat=1548172556_1ca79a5c74848db89885924730fc3393.CrossRef

Allahverdipour, H., Jalilian, F., & Shaghaghi, A. (2012). Vulnerability and the intention to anabolic steroids use among Iranian gym users: an application of the theory of planned behavior. Substance Use & Misuse, 47(3), 309–317. https://doi.org/10.3109/10826084.2011.633296 Retrieved from <Go to ISI>://WOS:000298856500010 https://www.tandfonline.com/doi/pdf/10.3109/10826084.2011.633296?needAccess=true.CrossRef

Alsaeed, I., & Alabkal, J. R. (2015). Usage and perceptions of anabolic-androgenic steroids among male fitness centre attendees in Kuwait--a cross-sectional study. Substance Abuse Treatment, Prevention & Policy, 10(1), 33–33. https://doi.org/10.1186/s13011-015-0030-5 31p. Retrieved from http://search.ebscohost.com/login.aspx?direct=true&db=rzh&AN=109631571&site=ehost-livehttps://substanceabusepolicy.biomedcentral.com/track/pdf/10.1186/s13011-015-0030-5.CrossRef

Alsamani, O., Tawfiq, S., Habib, H.U., Kotian, J., H H A (2017). The prevalence, knowledge, attitude and practice of using androgenic anabolic steroids (AAS) and powder protein supplements (PPS) amongst individual’s attending fitness centers in the Kingdom of Bahrain.

Althobiti, S. D., Alqurashi, N. M., Alotaibi, A. S., Alharthi, T. F., & Alswat, K. A. (2018). Prevalence, attitude, knowledge, and practice of anabolic androgenic steroid (AAS) use among gym participants. Materia socio-medica, 30(1), 49–52. https://doi.org/10.5455/msm.2018.30.49-52 Retrieved from <Go to ISI>://MEDLINE:29670477 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5857039/pdf/MSM-30-49.pdf.CrossRefPubMedPubMedCentral

Angoorani, H., & Halabchi, F. (2015). The misuse of anabolic-androgenic steroids among iranian recreational male body-builders and their related psycho-sociodemographic factors. Iran J Public Health, 44(12), 1662–1669 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26811817https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4724739/pdf/IJPH-44-1662.pdf.PubMedPubMedCentral

Arksey, H., & O’Malley, L. (2005). Scoping studies: towards a methodological framework. International Journal of Social Research Methodology, 8(1), 19–32 Retrieved from. 10.1080/1364557032000119616.CrossRef

Aslam, M. (2012). Gender-based explosions: The nexus between Muslim masculinities, jihadist Islamism and terrorism. New York: United Nations University Press.

Asr, M. H. S., Bashirian, S., Moghadam, R. H., Barati, M., & Moeini, B. (2018). Personal and psychosocial factors associated with anabolic-androgenic steroid use among Iranian male bodybuilders. Journal of Substance Use, 23(4), 390–395. https://doi.org/10.1080/14659891.2018.1436600 Retrieved from <Go to ISI>://WOS:000432212700009 https://www.tandfonline.com/doi/pdf/ 10.1080/14659891.2018.1436600 ?needAccess=true.CrossRef

Baggish, A. L., Weiner, R. B., Kanayama, G., Hudson, J. I., Lu, M. T., Hoffmann, U., & Pope Jr., H. G. (2017). Cardiovascular toxicity of illicit anabolic-androgenic steroid use. Circulation, 135(21), 1991–2002. https://doi.org/10.1161/CIRCULATIONAHA.116.026945 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28533317.CrossRefPubMedPubMedCentral

Bahri, A., Mahfouz, M. S., Marran, N. M., Dighriri, Y. H., Alessa, H. S., Khwaji, M. O., & Zafar, S. M. (2017). Prevalence and awareness of anabolic androgenic steroid use among male body builders in Jazan, Saudi Arabia. Tropical Journal of Pharmaceutical Research, 16(6), 1425–1430.CrossRef

Bahrke, M. S., Yesalis 3rd, C. E., & Wright, J. E. (1996). Psychological and behavioural effects of endogenous testosterone and anabolic-androgenic steroids. An update. Sports Med, 22(6), 367–390 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/8969015.CrossRef

Bahrke, M. S., Yesalis, C. E., & Wright, J. E. (1990). Psychological and behavioral-effects of endogenous testosterone levels and anabolic-androgenic steroids among males - a review. Sports Medicine, 10(5), 303–337. https://doi.org/10.2165/00007256-199010050-00003 Retrieved from <Go to ISI>://WOS:A1990ED90300003 https://link.springer.com/content/pdf/10.2165%2F00007256-199010050-00003.pdf.CrossRefPubMed

Baker, J. S., Thomas, N. E., Davies, B., & Graham, M. R. (2008). Anabolic androgenic steroid (AAS) abuse: not only an elite performance issue? TOSMJ, 2(1), 38–39. https://doi.org/10.2174/1874387000802010038 Retrieved from https://benthamopen.com/ABSTRACT/TOSMJ-2-38.CrossRef

Bates, G., Hope, V., & McVeigh, J. (2017). HIV among people using anabolic steroids in the United Kingdom: an overview. HIV Nursing: Sharing best practice in HIV care, 17(20–23).

Bates, G., & McVeigh, J. (2016). Image and performance enhancing drugs 2015 survey results. Retrieved from Centre for Public Health.

Bates, G., Tod, D., Leavey, C., & McVeigh, J. (2018). An evidence-based socioecological framework to understand men’s use of anabolic androgenic steroids and inform interventions in this area (pp. 1–9). Drugs: Education, Prevention and Policy. https://doi.org/10.1080/09687637.2018.1488947.

Begley, E., McVeigh, J., Hope, V., Bates, G., Glass, R., Campbell, J., . . . Smith, J. (2017). Image and performance enhancing drugs: 2016 National Survey Results. Retrieved from Liverpool.

Behre, H. M., Abshagen, K., Oettel, M., Hubler, D., & Nieschlag, E. (1999). Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies. European Journal of Endocrinology, 140, 414–419.CrossRef

Bjornebekk, A., Walhovd, K. B., Jorstad, M. L., Due-Tonnessen, P., Hullstein, I. R., & Fjell, A. M. (2017). Structural brain imaging of long-term anabolic-androgenic steroid users and nonusing weightlifters. Biol Psychiatry, 82(4), 294–302. https://doi.org/10.1016/j.biopsych.2016.06.017 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27616036. https://ac.elscdn.com/S000632231632529X/1-s2.0-S000632231632529X-main.pdf?_tid=ab42cb48-0839-11e8-9e50-00000aacb35e&acdnat=1517590621_5a4b85c8d999d2f6e0e2c74fa54620c7.CrossRefPubMed

Boos, C., Wheble, G. A. C., Campbell, M. J., Tabner, K. C., & Woods, D. R. (2010). Self-administration of exercise and dietary supplements in deployed British military personnel during operation TELIC 13. Journal of the Royal Army Medical Corps, 156(1), 32. https://doi.org/10.1136/jramc-156-01-07 Retrieved from http://jramc.bmj.com/content/156/1/32.abstract.CrossRefPubMed

Boos, C. J., Simms, P., Morris, F. R., & Fertout, M. (2011). The use of exercise and dietary supplements among British soldiers in Afghanistan. Journal of the Royal Army Medical Corps, 157(3), 229–232. https://doi.org/10.1136/jramc-157-03-08.CrossRefPubMed

Bordbar, M. R. F., Abdollahian, E., Samadi, R., & Dolatabadi, H. (2014). Frequency of use, awareness, and attitudes toward side effects of anabolic-androgenic steroids consumption among male medical students in Iran. Substance Use & Misuse, 49(13), 1751–1758. https://doi.org/10.3109/10826084.2014.880175 Retrieved from <Go to ISI>://WOS:000343678600001 https://www.tandfonline.com/doi/pdf/10.3109/10826084.2014.880175?needAccess=true.CrossRef

Boulad, N. E. (2003). Steroid abuse claims lives at Jordan gyms. Arij Net, p. http://arij.net/node/5892

Brandt, S. D., King, L. A., & Evans-Brown, M. (2014). The new drug phenomenon. Drug Testing and Analysis, 6(7–8), 587–597. https://doi.org/10.1002/dta.1686.CrossRefPubMed

Brennan, R., Wells, J. S., & Van Hout, M. C. (2016). The injecting use of image and performance-enhancing drugs (IPED) in the general population: a systematic review. Health Soc Care Community. https://doi.org/10.1111/hsc.12326 Retrieved from. http://www.ncbi.nlm.nih.gov/pubmed/26806443.

Cassler, N. M., Sams, R., Cripe, P. A., McGlynn, A. F., Perry, A. B., & Banks, B. A. (2013). Patterns and perceptions of supplement use by U.S. Marines deployed to Afghanistan. Military Medicine, 178(6), 659–664. https://doi.org/10.7205/milmed-d-12-00440.CrossRefPubMed

Chandler, M., & McVeigh, J. (2014). Steroids and image enhancing drugs 2013 survey results. Liverpool: LJMU Centre for Public Health.

Cohen, J., Collins, R., Darkes, J., & Gwartney, D. (2007). A league of their own: demographics, motivations and patterns of use of 1,955 male adult non-medical anabolic steroid users in the United States. Journal of the International Society of Sports Nutrition, 4. https://doi.org/10.1186/1550-2783-4-12 Retrieved from <Go to ISI>://WOS:000207974300004 http://download.springer.com/static/pdf/338/art%253A10.1186%252F1550-2783-4-12.pdf?originUrl=http%3A%2F%2Fhttp%3A%2F%2Fjissn.biomedcentral.com%2Farticle%2F10.1186%2F1550-2783-4-12&token2=exp=1465212735~acl=%2Fstatic%2Fpdf%2F338%2Fart%25253A10.1186%25252F1550-2783-4-12.pdf*~hmac=1e8e31ac1875fecc3c6caffdab4a6384471da64ed1399721cfe7003350b77fb5.

Crabtree, S. A., Husain, F., & Spalek, B. (2017). Islam and social work. Bristol Policy Press.

Creagh, T. M., Rubin, A., & Evans, D. J. (1988). Hepatic tumours induced by anabolic steroids in an athlete. J Clin Pathol, 41(4), 441–443 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/2835401http://jcp.bmj.com/content/jclinpath/41/4/441.full.pdf.CrossRef

Crossley, M. (2007). Narrative analysis. In E. Lyons & A. Coyle (Eds.), Analysing Qualitative Data in Psychology (pp. 131–144). https://doi.org/10.4135/9781446207536 Retrieved from https://methods.sagepub.com/book/analysing-qualitative-data-in-psychology.CrossRef

Darwish, A. (2009). Masculinity in the Muslim World. altMuslimah (“altM”). Retrieved from http://www.altmuslimah.com/2011/12/masculinity_in_the_muslim_world/

Daudt, H. M. L., van Mossel, C., & Scott, S. J. (2013). Enhancing the scoping study methodology: A large, inter-professional team’s experience with Arksey and O’Malley’s framework. BMC Medical Research Methodology, 13(1), 48 Retrieved from 10.1186/1471-2288-13-48.CrossRef

Dimeo, P. (2007). A history of drug use in sport 1876–1976: beyond good and evil. Abingdon, UK: Routledge.

Donnelly, T. T., Al-Thani, A. B. M., Benjamin, K., Al-Khater, A. H., Fung, T. S., Ahmedna, M., & Welch, A. (2018). Arab female and male perceptions of factors facilitating and inhibiting their physical activity: Findings from a qualitative study in the Middle East. PLoS One, 13(7), e0199336. https://doi.org/10.1371/journal.pone.0199336.CrossRefPubMedPubMedCentral

Duchaine, D. (1989). Underground steroid handbook II. Venice (CA): HLR technical books.

Evans-Brown, M., Kimergard, A., & McVeigh, J. (2009). Elephant in the room? The methodological implications for public health research of performanceenhancing drugs derived from the illicit market. Drug Testing and Analysis, 1(7–8), 323–326. https://doi.org/10.1002/dta.74 Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000275020800002&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=7f77ca1697db64ccb27a8011c7ced90d; https://onlinelibrary.wiley.com/doi/pdf/10.1002/dta.74.CrossRefPubMed

Evans-Brown, M., McVeigh, J., Perkins, C., & Bellis, M. A. (2012). Human enhancement drugs: the emerging challenges to public health. Liverpool: North West Public Health Observatory.

Evans, N. A. (2004). Current concepts in anabolic-androgenic steroids. American Journal of Sports Medicine, 32(2), 534–542. https://doi.org/10.1177/0363546503262202.CrossRef

Fijan, A., Eftekhari, M., & Dashtabi, A. (2018). The prevalence of anabolic androgenic steroid misuse and its associated factors among bodybuilders in shiraz, Iran. International Journal of Nutrition Sciences, 3(3), 151–156.

Fincoeur, B., van de Ven, K., & Mulrooney, K. J. D. (2015). The symbiotic evolution of anti-doping and supply chains of doping substances: how criminal networks may benefit from anti-doping policy. Trends in Organized Crime, 18(3), 229–250. https://doi.org/10.1007/s12117-014-9235-7 Retrieved from <Go to ISI>://WOS:000416708400005 https://link.springer.com/content/pdf/10.1007%2Fs12117-014-9235-7.pdf.CrossRef

Glass, R., Hope, V. D., Njoroge, J., Edmundson, C., Smith, J., McVeigh, J., et al. (2019). Secondary distribution of injecting equipment obtained from needle and syringe programmes by people injecting image and performance enhancing drugs: England and Wales, 2012-15. Drug Alcohol Depend, 195, 40–44. https://doi.org/10.1016/j.drugalcdep.2018.11.021 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/30580202.CrossRefPubMed

Greenway, C. W., & Price, C. (2018). A qualitative study of the motivations for anabolic-androgenic steroid use: the role of muscle dysmorphia and self-esteem in long-term users. Performance Enhancement & Health, 6(1), 12–20. https://doi.org/10.1016/j.peh.2018.02.002.CrossRef

Habeeb, M. B., Kasim, W. J., Khamees, L. A., Hawi, M. M., & Khashoom, Q. N. (2012). Athletes’ perceptions toward substance use in Baghdad City. American Journal of Men’s Health, 6(6), 462–471. https://doi.org/10.1177/1557988312446508 Retrieved from http://jmh.sagepub.com/content/6/6/462.full.pdf.CrossRefPubMed

Haerinejad, M. J., Ostovar, A., Farzaneh, M. R., & Keshavarz, M. (2016). The prevalence and characteristics of performance-enhancing drug use among bodybuilding athletes in the south of Iran, Bushehr. Asian J Sports Med, 7(3), e35018. https://doi.org/10.5812/asjsm.35018 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27826400https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098234/pdf/asjsm-07-03-35018.pdf.CrossRefPubMedPubMedCentral

Hakansson, A., Mickelsson, K., Wallin, C., & Berglund, M. (2012). Anabolic androgenic steroids in the general population: User characteristics and associations with substance use. European Addiction Research, 18(2), 83–90. https://doi.org/10.1159/000333037 Retrieved from <Go to ISI>://WOS:000300407500006 https://www.karger.com/Article/Pdf/333037.CrossRefPubMed

Hearne, E., Grund, J.-P. C., Van Hout, M. C., & McVeigh, J. (2016). A scoping review of home-produced heroin and amphetamine-type stimulant substitutes: Implications for prevention, treatment, and policy. Harm Reduction Journal, 13(1), 14 Retrieved from. 10.1186/s12954-016-0105-2.CrossRef

Hitti, E. A., Melki, J. P., & Mufarrij, A. J. (2014). The prevalence and determinants of anabolic steroid use among fitness centre attendees in Lebanon. International SportMed Journal, 15(4), 391–401 Retrieved from http://search.ebscohost.com/login.aspx?direct=true&db=s3h&AN=112373957&site=ehost-live.

Hoberman, J. M. (1992). Mortal engines: The science of performance and the dehumanization of sport. Caldwell, NJ: The Blackburn Press.

Hoberman, J. M. (2001). Testosterone dreams. Berkeley, Ca: University of California Press.

Hoffman, J. R., Faigenbaum, A. D., Ratamess, N. A., Ross, R., Kang, J. I. E., & Tenenbaum, G. (2008). Nutritional supplementation and anabolic steroid use in adolescents. Medicine & Science in Sports & Exercise, 40(1), 15–24 Retrieved from. 10.1249/mss.0b013e31815a5181.CrossRef

Hope, V. D., McVeigh, J., Marongiu, A., Evans-Brown, M., Smith, J., Kimergard, A., et al. (2013). Prevalence of, and risk factors for, HIV, hepatitis B and C infections among men who inject image and performance enhancing drugs: a cross-sectional study. BMJ Open, 3(9), e003207. https://doi.org/10.1136/bmjopen-2013-003207 Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3773656/pdf/bmjopen-2013-003207.pdf–e003207.CrossRefPubMedPubMedCentral

Hussain, B., Khalily, M. T., Rehman, A. U., Masud, M., & Arouj, K. (2018). Prevalence of anabolic androgenic steroids usage among Pakistani athletes and its psychological/ legal consequences. The Shield - Research Journal of Physical Education & Sports Science, 13, 64–72.

Ip, E. J., Barnett, M. J., Tenerowicz, M. J., Kim, J. A., Wei, H., & Perry, P. J. (2010). Women and anabolic steroids: an analysis of a dozen users. Clin J Sport Med, 20(6), 475–481. https://doi.org/10.1097/JSM.0b013e3181fb5370 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/21079445https://insights.ovid.com/pubmed?pmid=21079445.CrossRefPubMed

Ip, E. J., Barnett, M. J., Tenerowicz, M. J., & Perry, P. J. (2011). The anabolic 500 survey: characteristics of male users versus nonusers of anabolic-androgenic steroids for strength training. Pharmacotherapy, 31(8), 757–766. https://doi.org/10.1592/phco.31.8.757 Retrieved from <Go to ISI>://WOS:000293437700006 https://onlinelibrary.wiley.com/doi/pdf/10.1592/phco.31.8.757.CrossRefPubMed

Ip, E. J., Trinh, K., Tenerowicz, M. J., Pal, J., Lindfelt, T. A., & Perry, P. J. (2015). Characteristics and behaviors of older male anabolic steroid users. J Pharm Pract, 28(5), 450–456. https://doi.org/10.1177/0897190014527319 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24643452.CrossRefPubMed

Jabari, M., Al-Shehri, H., Al-Faris, A., Al-Sayed, M., Algaeed, F., Al-Sobaie, N., & Al-Saleh, F. (2016). The prevalence of anabolic androgenic steroid use amongst athletes in Riyadh (Saudi Arabia). Electron Physician, 8(12), 3343–3347. https://doi.org/10.19082/3343 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28163846https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5279964/pdf/epj-08-3343.pdf.CrossRefPubMedPubMedCentral

Jacka, B., Peacock, A., Degenhardt, L., Bruno, R., Clare, P., Kemp, R., et al. (2017). Trends in PIEDs use among male clients of needle-syringe programs in Queensland, Australia; 2007–2015. Int J Drug Policy, 46, 74–78. https://doi.org/10.1016/j.drugpo.2017.05.048 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28651113.CrossRefPubMed

Jalilian, F., Allahverdipour, H., Moeini, B., & Moghimbeigi, A. (2011). Effectiveness of anabolic steroid preventative intervention among gym users: applying theory of planned behavior. Health Promot Perspect, 1(1), 32–40. https://doi.org/10.5681/hpp.2011.002 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24688897http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963614/pdf/hpp-1-32.pdf.CrossRefPubMedPubMedCentral

Kanayama, G., Hudson, J. I., & Pope, H. G. (2008). Long-term psychiatric and medical consequences of anabolic-androgenic steroid use: a looming public health concern? Drug and Alcohol Dependence, 98(1-2), 1–12. https://doi.org/10.1016/j.drugalcdep.2008.05.004 Retrieved from <Go to ISI>://WOS:000259768500001 https://ac.els-cdn.com/S0376871608001919/1-s2.0-S0376871608001919-main.pdf?_tid=ca7743fd-92ea-4152-8433-5148e70d7ff6&acdnat=1550504353_f5b877b9391dcf5c230611eadf41c1aa.CrossRefPubMedPubMedCentral

Kanayama, G., Kean, J., Hudson, J. I., & Pope Jr., H. G. (2013). Cognitive deficits in long-term anabolic-androgenic steroid users. Drug Alcohol Depend, 130(1-3), 208–214. https://doi.org/10.1016/j.drugalcdep.2012.11.008 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/23253252https://ac.els-cdn.com/S0376871612004498/1-s2.0-S0376871612004498-main.pdf?_tid=eb412cf8-0839-11e8-adcc-00000aab0f6c&acdnat=1517590729_8fb3490f1db539958fe5e4496dd0f72e.CrossRefPubMed

Kanayama, G., & Pope, H. G. (2018). History and epidemiology of anabolic androgens in athletes and non-athletes. Molecular and Cellular Endocrinology, 464(C), 4–13. https://doi.org/10.1016/j.mce.2017.02.039 Retrieved from <Go to ISI>://WOS:000427666200002 https://ac.els-cdn.com/S0303720717301521/1-s2.0-S0303720717301521-main.pdf?_tid=33fcb761-4538-4c3c-b88f-a8c584ec5fef&acdnat=1537533590_cac57969485cdbd854dde29ce4260c50https://ac.els-cdn.com/S0303720717301521/1-s2.0-S0303720717301521-main.pdf?_tid=89aaa5e6-dd10-4687-99eb-d1473127ead2&acdnat=1537533593_1f15c3956cfa30398044a8eba311b053.CrossRefPubMed

Kanayama, G., & Pope Jr., H. G. (2012). Illicit use of androgens and other hormones: recent advances. Curr Opin Endocrinol Diabetes Obes, 19(3), 211–219. https://doi.org/10.1097/MED.0b013e3283524008 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22450858.CrossRefPubMedPubMedCentral

Kargarfard, M., Shariat, A., Lam, E., Shaw, B., Shaw, I., & Nayyeri, F. (2015). Prevalence and perceptions toward anabolic androgenic steroid use amongst university students. Acta Medica Bulgarica, 42(2), 61–67. https://doi.org/10.1515/amb-2015-0019.CrossRef

Kashkin, K. B., & Kleber, H. D. (1989). Hooked on hormones - an anabolic-steroid addiction hypothesis. Jama-Journal of the American Medical Association, 262(22), 3166–3170. https://doi.org/10.1001/jama.262.22.3166 Retrieved from <Go to ISI>://WOS:A1989CB77000029 https://jamanetwork.com/journals/jama/article-abstract/379795.CrossRef

Khalil, H., Peters, M., Godfrey, C. M., McInerney, P., Soares, C. B., & Parker, D. (2016). An evidence-based approach to scoping reviews. Worldviews on Evidence-Based Nursing, 13(2), 118–123. https://doi.org/10.1111/wvn.12144.CrossRefPubMed

Khidir, A. M., & Mahmoud, A. A. (2018). Doping awareness, and knowledge among Sudanese athletes and sports players. World Journal of Pharmacy and Pharmaceutical Sciences, 7(2), 1410–1417.

Khullar, N., Scull, N. C., Deeny, M., & Hamdan, E. (2016). Prevalence and predictors of anabolic-androgenic steroid use among gym users in Kuwait: a preliminary study. International Journal of Men s Health, 15(2), 144–156.

Kicman, A. T. (2008). Pharmacology of anabolic steroids. British Journal of Pharmacology, 154(3), 502–521. https://doi.org/10.1038/bjp.2008.165 Retrieved from <Go to ISI>://WOS:000256133600003 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2439524/pdf/bjp2008165a.pdf.CrossRefPubMedPubMedCentral

Kimergard, A., & McVeigh, J. (2014). Environments, risk and health harms: a qualitative investigation into the illicit use of anabolic steroids among people using harm reduction services in the UK. BMJ OPEN, 4(6). https://doi.org/10.1136/bmjopen-2014-005275 Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339717100089&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=7f77ca1697db64ccb27a8011c7ced90dhttps://bmjopen.bmj.com/content/bmjopen/4/6/e005275.full.pdf.

Levac, D., Colquhoun, H., & O’Brien, K. K. (2010). Scoping studies: advancing the methodology. Implementation Science, 5(1), 69 Retrieved from 10.1186/1748-5908-5-69.CrossRef

Lindqvist, A. S., Moberg, T., Eriksson, B. O., Ehrnborg, C., Rosen, T., & Fahlke, C. (2013). A retrospective 30-year follow-up study of former Swedish-elite male athletes in power sports with a past anabolic androgenic steroids use: a focus on mental health. British Journal of Sports Medicine, 47(15). https://doi.org/10.1136/bjsports-2012-091340 Retrieved from <Go to ISI>://WOS:000324415300007 https://bjsm.bmj.com/content/bjsports/47/15/965.full.pdf.

Maycock, B. R., & Howat, P. (2007). Social capital: implications from an investigation of illegal anabolic steroid networks. Health Education Research, 22(6), 854–863. https://doi.org/10.1093/her/cym022 Retrieved from <Go to ISI>://WOS:000251198400009 http://her.oxfordjournals.org/content/22/6/854.full.pdf.CrossRefPubMed

McVeigh, J., & Begley, E. (2017). Anabolic steroids in the UK: an increasing issue for public health. Drugs: Education, Prevention and Policy, 24(3), 278–285. https://doi.org/10.1080/09687637.2016.1245713.CrossRef

Melki, J. P., Hitti, E. A., Oghia, M. J., & Mufarrij, A. A. (2015). Media exposure, mediated social comparison to idealized images of muscularity, and anabolic steroid use. Health Communication, 30(5), 473–484. https://doi.org/10.1080/10410236.2013.867007 Retrieved from <Go to ISI>://WOS:000349667500006.CrossRefPubMed

Mohammad, H. (2014). Anabolic-androgenic steroids amongst Kuwaiti males. College Student Journal, 48(1), 120–129.

Mottram, D. R. (2018). The evolution of doping and anti-doping in sport. In D. R. Mottram & N. Chester (Eds.), Drugs in Sport (7th ed., pp. 21–38). Abingdon, UK: Routledge.CrossRef

Mulligan, K., & Schambelan, M. (2002). Anabolic treatment with GH, IGF-I, or anabolic steroids in patients with HIV-associated wasting. Int J Cardiol, 85(1), 151–159 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/12163220https://www.sciencedirect.com/science/article/pii/S0167527302002474?via%3Dihub.CrossRef

Mulrooney, K., Van de Ven, K., & McVeigh, J. (2019). Steroid madness - has the dark side of anabolic-androgenic steroids (AAS) been over-stated? In K. Van de Ven, K. Mulrooney, & J. McVeigh (Eds.), Human enhancement drugs. Abingdon, Oxon: Routledge.

Nakhaee, M. R., Pakravan, F., & Nakhaee, N. (2013). Prevalence of use of anabolic steroids by bodybuilders using three methods in a city of Iran. Addiction & Health, 5(3–4), 77–82 Retrieved from http://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=24494162&site=ehost-live.

Nieschlag, E. (2006). Testosterone treatment comes of age: new options for hypogonadal men. Clin Endocrinol (Oxf), 65(3), 275–281. https://doi.org/10.1111/j.1365-2265.2006.02618.x Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16918944.CrossRef

Nilsson, S. (2001). The prevalence of the use of androgenic anabolic steroids by adolescents in a county of Sweden. The European Journal of Public Health, 11(2), 195–197. https://doi.org/10.1093/eurpub/11.2.195 Retrieved from http://eurpub.oxfordjournals.org/content/eurpub/11/2/195.full.pdf.CrossRefPubMed

Nilsson, S., Spak, F., Marklund, B., Baigi, A., & Allebeck, P. (2005). Attitudes and behaviors with regards to androgenic anabolic steroids among male adolescents in a county of Sweden. Substance Use & Misuse, 39(8), 1183–1197. https://doi.org/10.1081/ja-120030060.CrossRef

Parkinson, A. B., & Evans, N. A. (2006). Anabolic androgenic steroids: a survey of 500 users. Medicine and Science in Sports and Exercise, 38(4), 644–651. https://doi.org/10.1249/01.mss.0000210194.56834.5d Retrieved from <Go to ISI>://WOS:000236806100006 http://ovidsp.tx.ovid.com/ovftpdfs/FPDDNCJCNFHANN00/fs046/ovft/live/gv023/00005768/00005768-200604000-00006.pdfhttp://ovidsp.tx.ovid.com/ovftpdfs/FPDDNCLBIHFCFP00/fs046/ovft/live/gv023/00005768/00005768-200604000-00006.pdf.CrossRefPubMed

Peters, M. D. J., Godfrey, C. M., Khalil, H., McInerney, P., Parker, D., & Soares, C. B. (2015). Guidance for conducting systematic scoping reviews. International Journal of Evidence-Based Healthcare, 13(3), 141–146. https://doi.org/10.1097/xeb.0000000000000050 Retrieved from https://journals.lww.com/ijebh/Fulltext/2015/09000/Guidance_for_conducting_systematic_scoping_reviews.5.aspx.CrossRefPubMed

Petersson, A., Bengtsson, J., Voltaire-Carlsson, A., & Thiblin, I. (2010). Substance abusers’ motives for using anabolic androgenic steroids. Drug Alcohol Depend, 111(1-2), 170–172. https://doi.org/10.1016/j.drugalcdep.2010.04.008 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20483546.CrossRefPubMed

Pope, C. G., Pope, H. G., Menard, W., Fay, C., Olivardia, R., & Phillips, K. A. (2005). Clinical features of muscle dysmorphia among males with body dysmorphic disorder. Body Image, 2(4), 395–400. https://doi.org/10.1016/j.bodyim.2005.09.001 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17075613.CrossRefPubMedPubMedCentral

Pope, H. G., & Kanayama, G. (2012). Anabolic–androgenic steroids. In Drug Abuse and Addiction in Medical Illness (pp. 251-264): Springer Science + Business Media.

Pope, H. G., Kanayama, G., Athey, A., Ryan, E., Hudson, J. I., & Baggish, A. (2014a). The lifetime prevalence of anabolic-androgenic steroid use and dependence in Americans: current best estimates. Am J Addict, 23(4), 371–377. https://doi.org/10.1111/j.1521-0391.2013.12118.x Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/24112239.CrossRefPubMed

Pope, H. G., Kanayama, G., & Hudson, J. I. (2012). Risk factors for illicit anabolic-androgenic steroid use in male weightlifters: a cross-sectional cohort study. Biological Psychiatry, 71(3), 254–261. Retrieved from https://doi.org/10.1016/j.biopsych.2011.06.024http://ac.els-cdn.com/S000632231100669X/1-s2.0-S000632231100669X-main.pdf?_tid=bc961e78-15e1-11e6-b16800000aab0f6b&acdnat=1462797175_1b929e5d9e436987fd7f0ec68545c9cb. https://doi.org/10.1016/j.biopsych.2011.06.024.CrossRefPubMed

Pope, H. G., Kouri, E. M., & Hudson, J. I. (2000). Effects of supraphysiologic doses of testosterone on mood and aggression in normal men - a randomized controlled trial. Archives of General Psychiatry, 57(2), 133–140. https://doi.org/10.1001/archpsyc.57.2.133 Retrieved from <Go to ISI>://WOS:000085086100003 http://archpsyc.jamanetwork.com/article.aspx? articleid=481565 https://jamanetwork.com/journals/jamapsychiatry/articlepdf/481565/yoa8259.pdf.CrossRefPubMed

Pope, H. G., Wood, R. I., Rogol, A., Nyberg, F., Bowers, L., & Bhasin, S. (2014b). Adverse health consequences of performance-enhancing drugs: an endocrine society scientific statement. Endocrine Reviews, 35(3), 341–375. https://doi.org/10.1210/er.2013-1058 Retrieved from <Go to ISI>://WOS:000337500600001 https://watermark.silverchair.com/edrv0341.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAccwggHDBgkqhkiG9w0BBwagggG0MIIBsAIBADCCAakGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMmEeri1Z6NU7JHlJHAgEQgIIBeunYbM1N8Uw35rYHydyGDjvdHLwTZA_IKX8O0vY3j9qHIRWQsxvP4dSNyjyyDBmvyVxWc17uBOlqaW3jRx1CUD6PO7vVWcUqiekXGBOL_MyYgdSrfMEv7lYUTeusTJH46PTi-Ldl1iv1cAfHF4eLBiyTQOhvCVqN_-IC5gRy4p5IekNCxn0kTr2tTzVqCdKhRSXcDPDN35WipVT4GMOWqOXCV6OUC0089tsP7KN2EbOOM7_z83-pzMVxiTjqgb2Gh-l6j6xn0gc3f14kX6Ji9Zd06qtbdDOnA-O81i6DneHuHY6G4o3gwg_EL7tfwl80046tK4zIZtDVcCFpoM-d8CrEVh5LREohwadPrLNVsTTaRG74xyoRZEcwvvEtkZVwV7TIg37JRgO3DDNZlrbC8FdmVQriacmQ1eDNk3Z8cTervYurnmDQMcoag1sYLQ.CrossRefPubMed

Rachoń, D., Pokrywka, L., & Suchecka-Rachoń, K. (2006). Prevalence and risk factors of anabolic-androgenic steroids (AAS) abuse among adolescents and young adults in Poland. Soz.-Präventivmed., 51(6), 392–398. https://doi.org/10.1007/s00038-006-6018-1 Retrieved from http://download.springer.com/static/pdf/327/art%253A10.1007%252Fs00038-006-6018-1.pdf?originUrl=http%3A%2F%2Flink.springer.com%2Farticle%2F10.1007%2Fs00038-006-6018-1&token2=exp=1462806169~acl=%2Fstatic%2Fpdf%2F327%2Fart%25253A10.1007%25252Fs00038-006-6018-1.pdf%3ForiginUrl%3Dhttp%253A%252F%252Flink.springer.com%252Farticle%252F10.1007%252Fs00038-006-60181*~hmac=d94cf35d66d28ac7c07880d08eadf2c0403be4f3abccbd2d3b2956502fa3f9df.CrossRefPubMed

Razavi, Z., Moeini, B., Shafiei, Y., & Bazmamoun, H. (2014). Prevalence of anabolic steroid use and associated factors among body-builders in Hamadan, west province of Iran. J Res Health Sci, 14(2), 163–166 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/24728754http://jrhs.umsha.ac.ir/index.php/JRHS/article/view/1255/.PubMed

Rezaei, S. M. A. (2017). Study the prevalence of anabolic steroids consumption among bodybuilding athletes in Yasuj, Iran. Int J Nutr Sci, 2(2), 103–108.

Saeidinejat, S., Hooshmand, E., Zahra, H., & Vafaee, A. (2017). Evaluating the pattern of anabolic androgenic steroid use and its relation with mental health of male members of bodybuilding clubs of Iran, in 2015. Asian Journal of Sports Medicine, 8(3).

Sagoe, D., Andreassen, C. S., Molde, H., Torsheim, T., & Pallesen, S. (2014a). Prevalence and correlates of anabolic–androgenic steroid use in a nationally representative sample of 17-year-old Norwegian adolescents. Substance Use & Misuse, 50(2), 139–147. https://doi.org/10.3109/10826084.2014.958859 Retrieved from https://www.tandfonline.com/doi/pdf/10.3109/10826084.2014.958859?needAccess=true.CrossRef

Sagoe, D., McVeigh, J., Bjornebekk, A., Essilfie, M. S., Andreassen, C. S., & Pallesen, S. (2015). Polypharmacy among anabolic-androgenic steroid users: a descriptive metasynthesis. Substance Abuse Treatment Prevention And Policy, 10(ARTN 12). https://doi.org/10.1186/s13011-015-0006-5 Retrieved from http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000351991500001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=7f77ca1697db64ccb27a8011c7ced90d; https://substanceabusepolicy.biomedcentral.com/track/pdf/10.1186/s13011-015-0006-5.

Sagoe, D., Molde, H., Andreassen, C. S., Torsheim, T., & Pallesen, S. (2014b). The global epidemiology of anabolic-androgenic steroid use: a meta-analysis and meta-regression analysis. Annals of Epidemiology, 24(5), 383–398. https://doi.org/10.1016/j.annepidem.2014.01.009 Retrieved from <Go to ISI>://WOS:000335712500009 http://ac.elscdn.com/S1047279714000398/1-s2.0-S1047279714000398-main.pdf?_tid=4c1a259e-16a5-11e6-9324-cdn.com/S1047279714000398/1-s2.0-S1047279714000398-main.pdf?_tid=4c1a259e-16a5-11e6-9324-00000aab0f27&acdnat=1462881168_90839f9eb42ecfeb1baf690267d01487.CrossRefPubMed

Sagoe, D., & Pallesen, S. (2018). Androgen abuse epidemiology. Curr Opin Endocrinol Diabetes Obes, 25(3), 185–194. https://doi.org/10.1097/MED.0000000000000403 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/29369917https://insights.ovid.com/pubmed?pmid=29369917.CrossRefPubMed

Salaymeh, L. (2015). Islamic law.

Santos, H. G., & Coomber, R. (2017). The risk environment of anabolic-androgenic steroid users in the UK: examining motivations, practices and accounts of use. Int J Drug Policy, 40, 35–43. https://doi.org/10.1016/j.drugpo.2016.11.005 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27955960https://ac.els-cdn.com/S0955395916303401/1-s2.0-S0955395916303401-main.pdf?_tid=ca45f920-0834-11e8-be2e-00000aab0f6b&acdnat=1517588526_cad445221644dbfa442ebb59d7f02277.CrossRef

Sarosdy, M. F. (2007). Male hypogonadism: an update on diagnosis and treatment. Cancer, 109(3), 536–541.CrossRef

Schumacher, J., Muller, G., & Klotz, K. F. (1999). Large hepatic hematoma and intraabdominal hemorrhage associated with abuse of anabolic steroids. New England Journal of Medicine, 340(14), 1123–1124. https://doi.org/10.1056/Nejm199904083401420 Retrieved from <go to ISI>://WOS:000079587000028 https://www.nejm.org/doi/pdf/10.1056/NEJM199904083401420.CrossRef

Sepehri, G., Mousavi Fard, M., & Sepehri, E. (2009). Frequency of anabolic steroids abuse in bodybuilder athletes in Kerman City†This article has been published in the Journal of Rafsanjan University of Medical Sciences in Persian language. Addiction & Health, 1(1), 25–29 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/24494079https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3905495/.

Sobhanian, S., Rajabian, D., Sadeghi, F., & Parsayee Manesh, E. (2013). Frequency of the use of anabolic drugs in bodybuilding athletes in Jahrom city. Journal of Jahrom University of Medical Sciences, 11, 30–34.

Tahtamouni, L. H., Mustafa, N. H., Alfaouri, A. A., Hassan, I. M., Abdalla, M. Y., & Yasin, S. R. (2008). Prevalence and risk factors for anabolic-androgenic steroid abuse among Jordanian collegiate students and athletes. The European Journal of Public Health, 18(6), 661–665. https://doi.org/10.1093/eurpub/ckn062 Retrieved from http://eurpub.oxfordjournals.org/content/eurpub/18/6/661.full.pdfhttps://watermark.silverchair.com/ckn062.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAkEwggI9BgkqhkiG9w0BBwagggIuMIICKgIBADCCAiMGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMHHYjz93vvSr7JEuhAgEQgIIB9N1dwqz5O3o3K0gYopzuZB69ys8LwKfbnHvooM7tnfBIdXAjIg6EbTJAAyZm3N1oId9hfeBYUG3fx9wpNdVSps5TdMz3mH4TFtCs4TUQlq8fuFPNnnoaH6Pvuk4ZaOMl5D0OicVRSOweyKgwXBbzcPF4wMP6jqry_U6HQLRRVaKIUbCIhCZ4F_InMnLeyaVVvINl6xW3hC84AUszUvXZKoMNFMKs1BLiW8wfm3KT4dX9Ma_xwZXMZk7cAhbHUzvFiWn7_iTz1j2CXUXmoj08w8NUwhIhbLgNEUwl6lSxPgq2Obhj9X53cmrGZmidOIOIMU7tfIfeUF_Jbp9sY9uV_5rv8krpCMKrSqolbmzgv56cUBqbymXMURpQte0HJSldnaceEKeQJtZPTZzggvmuXRXVEXPAQ5c8qSQTlF5hJ4qGe1u6eW94A58KtSg8qiLYrr3ea6uPmT9pZ4HzxQnzESg40ZU6mmmB0dM_7_3czh7nd8t302WGUr2m0m1Z7tEElTTEjw98j.CrossRefPubMed

Taylor, W. N. (2002). Anabolic therapy in modern medicine. Jefferson, NC: McFarland & Company, Inc, Publishers.

Tokish, J. M., Kocher, M. S., & Hawkins, R. J. (2004). Ergogenic aids: a review of basic science, performance, side effects, and status in sports. Am J Sports Med, 32(6), 1543–1553. https://doi.org/10.1177/0363546504268041 Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15310585.CrossRefPubMed

Tricco, A. C., Lillie, E., Zarin, W., O’Brien, K., Colquhoun, H., Kastner, M., et al. (2016). A scoping review on the conduct and reporting of scoping reviews. BMC Medical Research Methodology, 16, 15–15. https://doi.org/10.1186/s12874-016-0116-4 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/26857112https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746911/.CrossRefPubMedPubMedCentral

Uddin, Z., Iqbal, Q., Haider, S., & Saleem, F. (2019). Usage and perceptions of anabolic-androgenic steroids among male gym attendees in Quetta city, Pakistan–a descriptive analysis. Research in Pharmacy and Health Sciences, 5(2), 152–157.CrossRef

van de Ven, K., Zahnow, R., McVeigh, J., & Winstock, A. (2019). The modes of administration of anabolic-androgenic steroid users (AAS): are non-injecting people who use steroids overlooked? (pp. 1–5). Education, Prevention and Policy: Drugs. https://doi.org/10.1080/09687637.2019.1608910.

Van Hout, M. C. (2014). Kitchen chemistry: a scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions. Drug Testing and Analysis, 6(7–8), 778–787. https://doi.org/10.1002/dta.1622.CrossRefPubMed

Van Hout, M. C., & Kean, J. (2015). An exploratory study of image and performance enhancement drug use in a male British South Asian community. The International Journal of Drug Policy, 26(9), 860–867 Retrieved from <Go to ISI>://MEDLINE:25827056 http://www.ijdp.org/article/S0955-3959(15)00069-9/pdf.CrossRef

WADA. (2019). World Anti-Doping Code 2015 with 2019 amendments. Retrieved from Montreal: https://www.wadaama.org/sites/default/files/resources/files/wada_anti-doping_code_2019_english_final_revised_v1_linked.pdf

Wazaify, M., Bdair, A., Al-Hadidi, K., & Scott, J. (2014). Doping in gymnasiums in Amman: the other side of prescription and nonprescription drug abuse. Substance Use & Misuse, 49(10), 1296–1302. https://doi.org/10.3109/10826084.2014.891625 Retrieved from http://search.ebscohost.com/login.aspx?direct=true&db=cmedm&AN=24611822&site=ehost-live.CrossRef

Westerman, M. E., Charchenko, C. M., Ziegelmann, M. J., Bailey, G. C., Nippoldt, T. B., & Trost, L. (2016). Heavy testosterone use among bodybuilders: an uncommon cohort of illicit substance users. Journal of Urology, 195(4), E1188–E1189 Retrieved from https://global.factiva.com/hp/printsavews.aspxpp=Print&hc=Publication.

Westlye, L. T., Kaufmann, T., Alnaes, D., Hullstein, I. R., & Bjornebekk, A. (2017). Brain connectivity aberrations in anabolic-androgenic steroid users. Neuroimage Clin, 13, 62–69. https://doi.org/10.1016/j.nicl.2016.11.014 Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/27942448https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5133655/pdf/main.pdf.CrossRefPubMed

WHO. (2019). WHO’s Eastern Mediterranean Region Countries. Retrieved from http://www.emro.who.int/countries.html

Yager, Z., & O’Dea, J. A. (2014). Relationships between body image, nutritional supplement use, and attitudes towards doping in sport among adolescent boys: implications for prevention programs. Journal of the International Society of Sports Nutrition, 11. https://doi.org/10.1186/1550-2783-11-13 Retrieved from <Go to ISI>://WOS:000334715400001 https://jissn.biomedcentral.com/track/pdf/10.1186/1550-2783-11-13. Artn 13.

Yesalis, C. E. (2000). Anabolic steroids in sport and exercise (2nd ed.). Champaign: Human Kinetics.

Yesalis, C. E. (2001). Use of steroids for self-enhancement: an epidemiologic/societal perspective. AIDS Reader, 11(3), 157–161.

Zafar, R., Waseem, W., Akhtar, H., & Rabia, G. (2018). Weight lifters maltreatment of anabolic steroids in twin cities of Pakistan. RADS Journal of Pharmacy and Pharmaceutical Sciences, 6(4) Retrieved from http://jpps.juw.edu.pk/index.php/jpps/article/view/241/183.

Zahnow, R., McVeigh, J., Bates, G., Hope, V., Kean, J., Campbell, J., & Smith, J. (2018). Identifying a typology of men who use anabolic androgenic steroids (AAS). The International Journal of Drug Policy, 55, 105–112 Retrieved from https://ac.els-cdn.com/S0955395918300616/1-s2.0-S0955395918300616-main.pdf?_tid=59ce28a0-d1f9-4505-b3ec-dd09b60d52a7&acdnat=1550157796_2b9651fce38b637e3f9ed0d6744983fd.CrossRef

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Anabolic-Androgenic Steroid Use in the Eastern Mediterranean Region: a Scoping Review of Extant Empirical Literature

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2021

A New Parental Mentalization Focused Ultrasound Intervention for Substance Using Pregnant Women. Effect on Self-reported Prenatal Mental Health, Attachment and Mentalization in a Randomized and Controlled Trial

Methamphetamine-Related Emergency Department Visits Requiring Psychiatric Admission: A Retrospective Cohort Study

How and Where to Find NPS Users: a Comparison of Methods in a Cross-National Survey Among Three Groups of Current Users of New Psychoactive Substances in Europe

Histrionic Personality, Narcissistic Personality, and Problematic Social Media Use: Testing of a New Hypothetical Model

A Longitudinal Analysis of Peer Victimization, Self-Esteem, and Rejection Sensitivity in Mental Health and Substance Use Among Adolescents

Mattering, Insecure Attachment, Rumination, and Self-Criticism in Distress Among University Students